Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Rossmann MP"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rossmann MP; Department of Biomedical Genetics and Wilmot Cancer Institute, University of Rochester Medical Center., Palis J; Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA.
Publikováno v:
Current opinion in hematology [Curr Opin Hematol] 2024 May 01; Vol. 31 (3), pp. 71-81. Date of Electronic Publication: 2024 Feb 27.
Autor:
García-Castillo J; Grupo de Telomerasa, Cáncer y Envejecimiento, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain., Alcaraz-Pérez F; Grupo de Telomerasa, Cáncer y Envejecimiento, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, 30100 Murcia, Spain., Martínez-Balsalobre E; Grupo de Telomerasa, Cáncer y Envejecimiento, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, 30100 Murcia, Spain.; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain., García-Moreno D; Grupo de Telomerasa, Cáncer y Envejecimiento, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, 30100 Murcia, Spain.; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain., Rossmann MP; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115., Fernández-Lajarín M; Grupo de Telomerasa, Cáncer y Envejecimiento, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, 30100 Murcia, Spain.; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain., Bernabé-García M; Grupo de Telomerasa, Cáncer y Envejecimiento, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain., Pérez-Oliva AB; Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, 30100 Murcia, Spain.; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain., Rodríguez-Cortez VC; Josep Carreras Leukemia Research Institute, University of Barcelona, 08036 Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, 08036 Barcelona, Spain.; Instituciò Catalana de Recerca i Estudis Avançats, 08036 Barcelona, Spain., Bueno C; Josep Carreras Leukemia Research Institute, University of Barcelona, 08036 Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, 08036 Barcelona, Spain.; Instituciò Catalana de Recerca i Estudis Avançats, 08036 Barcelona, Spain., Adatto I; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115., Agarwal S; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115., Menéndez P; Josep Carreras Leukemia Research Institute, University of Barcelona, 08036 Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, 08036 Barcelona, Spain.; Instituciò Catalana de Recerca i Estudis Avançats, 08036 Barcelona, Spain., Zon LI; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115., Mulero V; Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, 30100 Murcia, Spain.; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain., Cayuela ML; Grupo de Telomerasa, Cáncer y Envejecimiento, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain; marial.cayuela@carm.es.; Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, 30100 Murcia, Spain.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Aug 10; Vol. 118 (32).
Autor:
Rossmann MP; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Howard Hughes Medical Institute, Boston, MA 02115, USA., Dubois SM; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Agarwal S; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Zon LI; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Howard Hughes Medical Institute, Boston, MA 02115, USA.
Publikováno v:
Disease models & mechanisms [Dis Model Mech] 2021 Jun 01; Vol. 14 (6). Date of Electronic Publication: 2021 Jun 11.
Autor:
Rossmann MP; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA., Hoi K; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA., Chan V; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA., Abraham BJ; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA., Yang S; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA., Mullahoo J; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Papanastasiou M; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Wang Y; Department of Biology, McGill University, Montréal, Québec H3A 1B1, Canada., Elia I; Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Perlin JR; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA., Hagedorn EJ; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA., Hetzel S; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany., Weigert R; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany., Vyas S; Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Nag PP; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Sullivan LB; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Warren CR; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Dorjsuren B; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA., Greig EC; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA., Adatto I; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA., Cowan CA; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Schreiber SL; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Young RA; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Meissner A; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany., Haigis MC; Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Hekimi S; Department of Biology, McGill University, Montréal, Québec H3A 1B1, Canada., Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Zon LI; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 01238, USA. leonard.zon@enders.tch.harvard.edu.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2021 May 14; Vol. 372 (6543), pp. 716-721.
Autor:
Rossmann MP; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Howard Hughes Medical Institute, Boston, Massachusetts, USA., Zon LI; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge.; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Howard Hughes Medical Institute, Boston, Massachusetts, USA.
Publikováno v:
Current opinion in hematology [Curr Opin Hematol] 2021 May 01; Vol. 28 (3), pp. 129-137.
Autor:
Tyrkalska SD; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain., Pérez-Oliva AB; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain. Electronic address: anabpo@um.es., Rodríguez-Ruiz L; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain., Martínez-Morcillo FJ; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain., Alcaraz-Pérez F; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain., Martínez-Navarro FJ; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain., Lachaud C; Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France., Ahmed N; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Schroeder T; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Pardo-Sánchez I; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain., Candel S; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain., López-Muñoz A; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain., Choudhuri A; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston, Howard Hughes Medical Institute, Boston, MA 02115, USA., Rossmann MP; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston, Howard Hughes Medical Institute, Boston, MA 02115, USA., Zon LI; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston, Howard Hughes Medical Institute, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Stem Cell Institute, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA., Cayuela ML; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain., García-Moreno D; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain. Electronic address: dianagm@um.es., Mulero V; Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain. Electronic address: vmulero@um.es.
Publikováno v:
Immunity [Immunity] 2019 Jul 16; Vol. 51 (1), pp. 50-63.e5. Date of Electronic Publication: 2019 Jun 04.
Autor:
Rossmann MP; Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA 02115, USA. Department of Medical Oncology and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA., Zhou Y; Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA 02115, USA. Department of Medical Oncology and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA., Zon LI; Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston, Howard Hughes Medical Institute and Harvard Medical School, Boston, MA 02115, USA. Department of Medical Oncology and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA. Electronic address: zon@enders.tch.harvard.edu.
Publikováno v:
Current biology : CB [Curr Biol] 2016 Oct 10; Vol. 26 (19), pp. R890-R892. Date of Electronic Publication: 2016 Oct 10.
Autor:
Yang S; Boston Children's Hospital, Boston, MA, United States; Dana Farber Cancer Institute, Harvard Stem Cell Institute, Boston, MA, United States; Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, United States., Ott CJ; Dana Farber Cancer Institute, Harvard Stem Cell Institute, Boston, MA, United States., Rossmann MP; Harvard University, Harvard, Cambridge, MA, United States., Superdock M; Boston Children's Hospital, Boston, MA, United States; Dana Farber Cancer Institute, Harvard Stem Cell Institute, Boston, MA, United States; Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, United States., Zon LI; Boston Children's Hospital, Boston, MA, United States; Dana Farber Cancer Institute, Harvard Stem Cell Institute, Boston, MA, United States; Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, United States; Harvard University, Harvard, Cambridge, MA, United States., Zhou Y; Boston Children's Hospital, Boston, MA, United States; Dana Farber Cancer Institute, Harvard Stem Cell Institute, Boston, MA, United States; Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, United States; Harvard University, Harvard, Cambridge, MA, United States.
Publikováno v:
Methods in cell biology [Methods Cell Biol] 2016; Vol. 135, pp. 387-412. Date of Electronic Publication: 2016 Jun 20.
Autor:
Rossmann MP; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA., Stillman B
Publikováno v:
Cold Spring Harbor protocols [Cold Spring Harb Protoc] 2013 Jul 01; Vol. 2013 (7), pp. 625-30. Date of Electronic Publication: 2013 Jul 01.